Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Authors
Batchelor, Tracy T.; Duda, Dan G.; di Tomaso, Emmanuelle; Ancukiewicz, Marek; Plotkin, Scott R.; Gerstner, Elizabeth; Eichler, April F.; Drappatz, Jan; Hochberg, Fred H.; Benner, Thomas; Louis, David N.; Cohen, Kenneth S.; Chea, Houng; Exarhopoulos, Alexis; Loeffler, Jay S.; Moses, Marsha A.; Ivy, Percy; Sorensen, A. Gregory; Wen, Patrick Y.; Jain, Rakesh K.
Publication
Journal of Clinical Oncology, 2010, Vol 28, Issue 17, p2817